Post-stroke administration of low-dose apelin-36 could attenuate infarct volume and apoptosis, which is associated with the inhibition of ERS/UPR activation. Low dose of apelin-13 had no protective effect in rats with ischemic stroke. Here, APLN is linked to stroke disorder.